OptimizeRx Corporation

(NASDAQ:OPRX)

Latest On OptimizeRx Corporation (OPRX):

Date/Time Type Description Signal Details
2023-05-11 09:05 ESTNewsOptimizeRx Corporation (OPRX) Q1 2023 Earnings Call TranscriptN/A
2023-05-10 19:14 ESTNewsOptimizeRx Non-GAAP EPS of -$0.09 misses by $0.01, revenue of $13M beats by $0.64MN/A
2023-05-10 05:58 ESTNewsOptimizeRx Q1 2023 Earnings PreviewN/A
2023-04-04 01:29 ESTNewsOptimizeRx Has A Good Growth Path AheadN/A
2023-03-14 08:26 ESTNewsOptimizeRx launches $15M stock buyback planN/A
2023-03-09 20:46 ESTNewsOptimizeRx bags contract with Hub services company for better patient accessN/A
2023-03-09 05:10 ESTNewsOptimizeRx Q4 results mixed, co sees FY 2023 Y/Y revenue growth below consensusN/A
2023-03-09 05:10 ESTNewsOptimizeRx Q4 top line miss, lackluster 2023 revenue guidance drives shares down 19%N/A
2023-03-09 05:10 ESTNewsOptimizeRx Corporation (OPRX) Q4 2022 Earnings Call TranscriptN/A
2022-11-09 10:21 ESTNewsOptimizeRx Corporation (OPRX) Q3 2022 Earnings Call TranscriptN/A
2022-11-08 17:11 ESTNewsOptimizeRx Non-GAAP EPS of $0.07 beats by $0.03, revenue of $15.1M beats by $0.08MN/A
2022-11-07 23:01 ESTNewsOptimizeRx Q3 2022 Earnings PreviewN/A
2022-10-25 15:02 ESTNewsOptimizeRx: A Digital Health Marketing Firm That Has Fallen On Hard TimesN/A
2022-10-12 08:35 ESTNewsOptimizeRx: A Top Candidate For My Speculative 'Bio Boom' PortfolioN/A
2022-08-10 21:45 ESTNewsOptimizeRx stock sinks 26% on Q2 miss, while FY22 outlook cut on life sciences sector woesN/A
2022-08-10 04:11 ESTNewsOptimizeRx Q2 Non-GAAP EPS, revenue misses, FY22 guidance below consensusN/A
2022-08-10 04:11 ESTNewsOptimizeRx Corporation (OPRX) CEO William Febbo on Q2 2022 Results - Earnings Call TranscriptN/A
2022-08-09 06:21 ESTNewsOptimizeRx Q2 2022 Earnings PreviewN/A
2022-07-26 19:41 ESTNewsOptimizeRx extends reach with Cooler Screens PartnershipN/A
2022-06-27 13:25 ESTNewsOptimizeRx: A Small-Cap Digital Health Technology Gem With Near-Term Inflection In ProfitabilityN/A
2022-06-26 19:34 ESTNewsOptimizeRx (OPRX) Investor Presentation - SlideshowN/A
2022-05-17 14:46 ESTNewsOptimizeRx authorizes $20M share repurchase programN/A
2022-05-05 07:30 ESTNewsOptimizeRx Non-GAAP EPS of -$0.01 in-line, revenue of $13.73M beats by $0.18MN/A
2022-05-05 07:29 ESTNewsOptimizeRx Corporation (OPRX) CEO William Febbo on Q1 2022 Results - Earnings Call TranscriptN/A
2022-05-03 18:55 ESTNewsOptimizeRx Q1 2022 Earnings PreviewN/A
2022-03-16 08:15 ESTNewsOptimizeRx to acquire specialty drug prescription platform EvincemedN/A
2022-02-25 12:37 ESTNewsOptimizeRx's (OPRX) CEO William Febbo on Q4 2021 Results - Earnings Call TranscriptN/A
2022-02-24 17:00 ESTNewsOptimizeRx Non-GAAP EPS of $0.22 beats by $0.18, revenue of $20.3M beats by $5.5MN/A
2022-02-24 00:04 ESTNewsOptimizeRx Q4 2022 Earnings PreviewN/A
2022-02-16 04:57 ESTNewsOptimizeRx announces preliminary Q4 resultsN/A
2021-11-10 13:38 ESTNewsOptimizeRx EPS misses by $0.04, beats on revenueN/A
2021-11-10 13:38 ESTNewsOptimizeRx's (OPRX) CEO William Febbo on Q3 2021 Results - Earnings Call TranscriptN/A
2021-11-09 14:32 ESTNewsOptimizeRx Q3 2021 Earnings PreviewN/A
2021-09-30 20:19 ESTNewsOptimizeRx names Edward Stelmakh as CFO and COON/A
2021-09-29 20:59 ESTNewsOptimizeRx jumps 11% on addition to SmallCap 600 indexN/A
2021-08-05 10:49 ESTNewsOptimizeRx Corporation (OPRX) CEO William Febbo on Q2 2021 Results - Earnings Call TranscriptN/A
2021-07-21 18:39 ESTNewsOptimizeRx inks collaboration agreement to drive new patient affordability initiativeN/A
2021-04-20 09:36 ESTNewsOptimizeRx Stock Is Just Getting StartedN/A
2021-03-17 05:40 ESTNewsOptimizeRx nabs 19 new enterprise-level engagements in Q1 leading to recurring revenueN/A
2021-03-02 12:13 ESTAnalyst RatingThe Analyst Target Price has increased from $65.33 to $75.33.Buy
2021-02-26 12:08 ESTAnalyst RatingThe Analyst Target Price has increased from $61.33 to $65.33.Buy
2021-02-26 04:22 ESTFinancialsCompany financials have been released.Neutral
2021-02-25 14:02 ESTEarnings EstimateAn EPS average of $0.07 is estimated for the quarter ending on June 30, 2021.Sell
2021-02-25 14:02 ESTEarnings EstimateAn EPS average of $0.78 is estimated for the 2022 year.Buy
2021-02-25 07:12 ESTNewsOptimizeRx EPS beats by $0.01, beats on revenueN/A
2021-02-25 07:10 ESTNewsOptimizeRx Corporation (OPRX) CEO William Febbo on Q4 2020 Results - Earnings Call TranscriptN/A
2021-02-10 16:32 ESTNewsOptimizeRx announces proposed public offeringN/A
2021-02-10 16:31 ESTNewsOptimizeRx priced its stock offeringN/A
2021-01-26 12:20 ESTAnalyst RatingThe Analyst Target Price has increased from $53.33 to $61.33.Buy
2021-01-25 20:45 ESTNewsOptimizeRx trades high on positive Q4 guidanceN/A

About OptimizeRx Corporation (OPRX):

OptimizeRx Corporation operates as a digital health company that provides communications solutions for life science companies, physicians, and patients. Its products and applications include financial messaging, a virtual patient support center that allows doctors and staff to access sample vouchers, co-pay coupons, and other patient support through their EMR and/or e-prescribe systems; and brand awareness and therapeutic support messaging services, such as brand awareness messages, reminder ads, therapeutic support messages, and unbranded messages. The company also offers brand support services, which focuses on educating and working with pharmaceutical manufacturers on identifying, formulating, and implementing new eRx media strategies, including drug file integration, sales force training, and strategy development services for promoting their products. In addition, it operates cloud based Mobile Health Messenger platform that provides interactive health messaging for enhanced medication adherence and care coordination; and HIPAA-compliant automated mobile messaging platform that allows pharmaceutical manufactures and related entities to directly engage with patients to enhance regimen compliance. Further, the company offers patient programs with treatment and affordability information, lifestyle and condition trackers, Internet device connectivity, forms, and surveys. OptimizeRx Corporation is headquartered in Rochester, Michigan.

OPRX Quotes by TradingView

See Advanced Chart

General

  • Name OptimizeRx Corporation
  • Symbol OPRX
  • Type Common Stock
  • Exchange NASDAQ
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryHealth Information Services
  • Full Time Employees 71
  • Last Split Factor1:3
  • Last Split Date2018-05-14
  • Fiscal Year EndDecember
  • IPO Date1996-10-22
  • Gic SectorHealth Care
  • Gic GroupHealth Care Equipment & Services
  • Gic IndustryHealth Care Technology
  • Gic SubIndustryHealth Care Technology
  • Web URLhttp://www.optimizerx.com
View More

Valuation

  • Forward PE 96.15
  • Price/Sales (Trailing 12 Mt.) 15.5
  • Price/Book (Most Recent Quarter) 15.23
  • Enterprise Value Revenue 17.34
  • Enterprise Value EBITDA 467.33
View More

Financials

  • Most Recent Quarter 2020-12-31
  • Current Year EPS Estimate $0.44
  • Next Year EPS Estimate $0.81
  • Next Quarter EPS Estimate $0.03
  • Profit Margin -5%
  • Operating Margin -3%
  • Return on Assets -1%
  • Return on Equity -5%
  • Revenue 43.31 million
  • Earnings Per Share $0.04
  • Revenue Per Share $2.92
  • Gross Profit 24.11 million
  • Quarterly Earnings Growth 122.6%
View More

Highlights

  • Market Capitalization 839.66 million
  • EBITDA 646895
  • PE Ratio -8.5
  • PEG Ratio 1.93
  • Analyst Target Price $75.33
  • Book Value Per Share $3.28
View More

Share Statistics

  • Shares Outstanding 16.81 million
  • Shares Float 14.36 million
  • % Held by Insiders 1791%
  • % Held by Institutions 65.76%
  • Shares Short 871014
  • Shares Short Prior Month 930303
  • Short Ratio 2.63
  • Short % of Float 5%
  • Short % of Shares Outstanding 5%
View More

Technicals

  • Beta 0.66
  • 52 Week High $63.98
  • 52 Week Low $6.51
  • 50 Day Moving Average 51.77
  • 200 Day Moving Average 32.49
View More

Dividends

  • Dividend Date 2018-05-14
  • ExDividend Date N/A
  • Dividend Yield 0%
View More

OptimizeRx Corporation (OPRX) Dividend Calendar:

OPRX's last dividend payment was made to shareholders on May 14, 2018.

Ex-Dividend Date Payment Date Record Date Declared Date Amount

OptimizeRx Corporation (OPRX) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-12-312021-02-24$N/A$0.16$0.163.23%
2020-09-302020-11-09$N/A$0.06$0.0455.75%
2020-06-302020-08-05$N/A$0.02-$0.03166.67%
2020-03-312020-05-04$N/A-$0.06-$0.03-100%
2019-12-312020-02-27$7.38 million-$0.03$0.01-700%
2019-09-302019-11-05$5 million-$0.05$0.08-164.52%
2019-06-302019-08-07$7.01 million$0.09$0.0816.13%
2019-03-312019-05-08$5.21 million$0.06$0.02166.67%
2018-12-312019-02-26$6.58 million$0.06$0.07-18.14%
2018-09-302018-11-05$5.42 million$0.07$0.0623%
2018-06-302018-08-07$5.1 million$0.07$0.03166.8%
2018-03-312018-05-02$4.11 million$0.03-$0.03205%
2017-12-312018-02-27$4.01 million$0.02-$0.03157%
2017-09-302017-11-02$3.1 million-$0.04-$0.03-43%
2017-06-302017-08-01$2.87 million-$0.03
2017-03-312017-05-03$2.15 million-$0.09
2016-12-312017-03-08$2.29 million-$0.04
2016-09-302016-11-07$1.79 million-$0.02
2016-06-302016-08-08$1.91 million-$0.03-$0.030%
2016-03-312016-05-09$1.76 million-$0.01-$0.0366.67%
2015-12-312016-03-15$2.02 million-$0.01
2015-09-302015-11-12$2.01 million$0.01
2015-06-302015-08-11$1.71 million-$0.01
2015-03-312015-05-14$1.49 million-$0.01
2014-12-312015-03-31$1.97 million$0.00$0.01-100%
2014-09-302014-11-13$1.82 million-$0.02
2014-06-302014-08-14$1.43 million-$0.01$0.03-122.67%
2014-03-312014-05-28$1.29 million-$0.12
2013-12-312013-12-31$1.53 million-$0.01
2013-09-302013-09-30$1.37 million$0.00
2013-06-302013-06-30$1.1 million$0.03
2013-03-312013-03-31$669000-$0.02
2012-12-312012-12-31$0.07
2012-09-302012-09-30-$0.02
2012-06-302012-06-30-$0.02
2012-03-312012-03-31-$0.06
2011-12-312011-12-31-$0.11
2011-09-302011-09-30$191593-$0.21
2011-06-302011-06-30$200174-$0.09
2011-03-312011-03-31-$0.05
2010-12-312010-12-31-$0.08
2010-09-302010-09-30-$0.11
2010-06-302010-06-30-$0.20
2010-03-312010-03-31-$0.06
2009-12-312009-12-31-$0.54
2009-09-302009-09-30-$0.12
2009-06-302009-06-30-$0.08
2009-03-312009-03-31-$0.33
2008-12-312008-12-31-$0.84
2008-09-302008-09-30-$0.04
2008-06-302008-06-30-$0.14
2008-03-312008-03-31-$158.21

OptimizeRx Corporation (OPRX) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date Dec 31 2020 Sep 30 2020 Jun 30 2020 Mar 31 2020 Dec 31 2019
Research Development N/A N/A N/A N/A N/A
Income Before Tax N/A N/A N/A -2.2 million -2.89 million
Selling General Administrative N/A N/A N/A N/A 5.76 million
Gross Profit N/A N/A N/A N/A 4.47 million
Ebit N/A N/A N/A N/A -2.32 million
Operating Income N/A N/A N/A -2.26 million -2.32 million
Income Tax Expense N/A N/A N/A N/A -897960
Total Revenue N/A N/A N/A N/A 7.38 million
Cost of Revenue N/A N/A N/A N/A 2.91 million
Total Other Income Expense Net N/A N/A N/A N/A -567278
Net Income From Continuing Operations N/A N/A N/A -2.2 million -1.99 million
Net Income Applicable to Common Shares 1.36 million -282894 -1.08 million -2.2 million -1.99 million
Cash Flow:
Date Sep 30 2020 Jun 30 2020 Mar 31 2020 Dec 31 2019 Sep 30 2019
Investments N/A N/A N/A N/A N/A
Change to Liabilities -203655 105896 -33471 -766603 530192
Total Cash Flow from Investing Activities -20256 -9061 -15937 -9.52 million -13718
Net Borrowings N/A N/A N/A N/A N/A
Total Cash Flow from Financial Activities N/A N/A 112152 113279 206324
Change to Operating Activities 1.52 million 1.51 million -1.23 million 310250 -824717
Change in Cash N/A N/A N/A -10.91 million -776453
Total Cash from Operating Activities -106598 127643 -3.74 million -1.5 million -969059
Depreciation N/A N/A N/A 536859 320055
Other Cash Flow from Investing Activities N/A N/A N/A N/A N/A
Change to Inventory N/A N/A N/A N/A N/A
Change to Account Receivables N/A N/A N/A 151719 266109
Other Cash Flow from Financing Activities -3 million -1.39 million N/A 301711 N/A
Change to Net Income 906827 850671 854512 252618 310244
Capital Expenditures N/A N/A N/A 26260 13718
Balance Sheet:
Date Dec 31 2020 Sep 30 2020 Jun 30 2020 Mar 31 2020 Dec 31 2019
Total Liabailities N/A N/A N/A 12.61 million 11.78 million
Total Stockholder Equity N/A N/A N/A N/A 44.86 million
Other Current Liabilities 6.87 million 5.71 million N/A N/A 3.7 million
Total Assets N/A N/A N/A 56.24 million 56.64 million
Common Stock 15223 15072 14753 14647 14601
Other Current Assets N/A N/A N/A N/A N/A
Retained Earnings -35.63 million -36.99 million -36.71 million -35.63 million -33.42 million
Other Liabilities N/A N/A N/A 2.72 million 5.22 million
Other Assets 12859 16013 35943 16013 80727
Cash N/A N/A N/A 15.21 million 18.85 million
Total Current Liabilities 10.03 million 8.11 million N/A 9.47 million 6.11 million
Other Stockholder Equity N/A N/A N/A N/A N/A
Property, Plant & Equipment 594828 626715 660056 701967 735877
Total Current Assets 32.86 million 27.23 million N/A N/A 27.14 million
Long Term Investments N/A N/A N/A N/A N/A
Net Tangible Assets 23.11 million 19.41 million 15.76 million 15.41 million 16.18 million
Short Term Investments N/A N/A N/A N/A N/A
Long Term Debt N/A N/A N/A N/A N/A
Inventory N/A N/A N/A N/A N/A
Accounts Payable 618250 480502 N/A N/A 492995

OptimizeRx Corporation (OPRX) Chart:

OptimizeRx Corporation (OPRX) News:

Below you will find a list of latest news for OptimizeRx Corporation (OPRX) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

OptimizeRx Corporation (OPRX) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent
2025-12-192.50CALL0 01339.78TRUE00
2025-12-19511.46CALL0 20TRUE00
2025-12-197.59.15CALL0 30TRUE00
2025-12-19109.2CALL0 0198.02TRUE00
2025-12-1912.51.68CALL10 206181.41TRUE1.680
2025-12-19150.25CALL0 336148.53FALSE00
2025-12-1917.50.3CALL0 587222.26FALSE00
2025-12-19200.01CALL0 160353.97FALSE00
2025-12-1922.50.44CALL0 20408.77FALSE00
2025-12-19250.36CALL0 6454.95FALSE00
2025-12-19300.5CALL0 11529.99FALSE00
2025-12-19350CALL0 0589.61FALSE00
2025-12-192.50PUT0 01388.1FALSE00
2025-12-1950PUT0 0823.34FALSE00
2025-12-197.50.45PUT0 5538.38FALSE00
2025-12-19101PUT0 1339.52FALSE00
2025-12-1912.50.15PUT0 19171.49FALSE00
2025-12-19151.33PUT10 5170TRUE-0.17-0.11
2025-12-1917.53.9PUT0 40TRUE00
2025-12-19205.98PUT0 1230TRUE00
2025-12-1922.50PUT0 0224.48TRUE00
2025-12-19250PUT0 00TRUE00
2025-12-19300PUT0 00TRUE00
2025-12-19350PUT0 00TRUE00
2026-01-162.50CALL0 0544.82TRUE00
2026-01-1650CALL0 0273.05TRUE00
2026-01-167.50CALL0 0182.03TRUE00
2026-01-16104.5CALL0 586.63TRUE00
2026-01-1612.52CALL0 3579.51TRUE00
2026-01-16150.45CALL10 8861.65FALSE-0.17-0.27
2026-01-1617.50.3CALL0 31673.91FALSE00
2026-01-16203.4CALL0 13148.11FALSE00
2026-01-1622.51.8CALL0 5171.17FALSE00
2026-01-16251.45CALL0 23190.59FALSE00
2026-01-16300.75CALL0 1222.15FALSE00
2026-01-16350.4CALL0 3247.22FALSE00
2026-01-162.50PUT0 0584.14FALSE00
2026-01-1650.1PUT0 3346.68FALSE00
2026-01-167.50PUT0 0226.93FALSE00
2026-01-16100PUT0 0143.41FALSE00
2026-01-1612.50.6PUT0 769.58FALSE00
2026-01-16151.77PUT10 4040.32TRUE1.770
2026-01-1617.52.42PUT0 1030TRUE00
2026-01-16200PUT0 00TRUE00
2026-01-1622.50PUT0 00TRUE00
2026-01-16258.8PUT0 00TRUE00
2026-01-16300PUT0 00TRUE00
2026-01-16350PUT0 00TRUE00
2026-02-202.514.78CALL0 20TRUE00
2026-02-2050CALL0 00TRUE00
2026-02-207.50CALL0 00TRUE00
2026-02-201010.65CALL0 1864.87TRUE00
2026-02-2012.52.9CALL0 2677.99TRUE00
2026-02-20151.85CALL0 81176.73FALSE00
2026-02-2017.51.79CALL0 22153.35FALSE00
2026-02-20203.13CALL0 34103.44FALSE00
2026-02-2022.50.25CALL0 40119.66FALSE00
2026-02-20251.8CALL0 5133.33FALSE00
2026-02-20300.5CALL0 1155.51FALSE00
2026-02-20351CALL0 1173.13FALSE00
2026-02-202.50PUT0 0410.95FALSE00
2026-02-2050PUT0 0244.06FALSE00
2026-02-207.50PUT0 0159.96FALSE00
2026-02-20100PUT0 0126.08FALSE00
2026-02-2012.51.4PUT0 174.25FALSE00
2026-02-20152.35PUT0 375.73TRUE00
2026-02-2017.50PUT0 073.47TRUE00
2026-02-20206.13PUT0 940TRUE00
2026-02-2022.56.2PUT0 170TRUE00
2026-02-20250PUT0 00TRUE00
2026-02-20300PUT0 00TRUE00
2026-02-20350PUT0 00TRUE00
2026-03-202.50CALL0 0310.7TRUE00
2026-03-20513.75CALL0 10TRUE00
2026-03-207.50CALL0 094.76TRUE00
2026-03-201011.05CALL0 1109.15TRUE00
2026-03-2012.53CALL0 33580.82TRUE00
2026-03-20151.93CALL10 1890.83FALSE0.080.04
2026-03-2017.51.05CALL0 7372.08FALSE00
2026-03-20200.56CALL50 13978FALSE0.560
2026-03-2022.54.5CALL0 10100.63FALSE00
2026-03-20252.18CALL0 2112.17FALSE00
2026-03-20300.75CALL0 3130.9FALSE00
2026-03-20350.62CALL0 12145.77FALSE00
2026-03-202.50PUT0 0347.14FALSE00
2026-03-2050PUT0 0206.28FALSE00
2026-03-207.50.4PUT0 10121.98FALSE00
2026-03-20100.55PUT0 11178.43FALSE00
2026-03-2012.51.65PUT0 3080.8FALSE00
2026-03-20151.7PUT0 394.84TRUE00
2026-03-2017.53.92PUT0 267.63TRUE00
2026-03-20200PUT0 047.52TRUE00
2026-03-2022.50PUT0 00TRUE00
2026-03-20258.9PUT0 200TRUE00
2026-03-20300PUT0 00TRUE00
2026-03-20350PUT0 00TRUE00
2026-06-182.50CALL0 0272.22TRUE00
2026-06-1850CALL0 0149.61TRUE00
2026-06-187.50CALL0 0138.54TRUE00
2026-06-18100CALL0 085.82TRUE00
2026-06-1812.54.95CALL0 488.23TRUE00
2026-06-18153.2CALL0 586.54FALSE00
2026-06-1817.57.79CALL0 378.71FALSE00
2026-06-18201.97CALL0 8384.66FALSE00
2026-06-1822.52.07CALL0 391.83FALSE00
2026-06-18253.3CALL0 583.55FALSE00
2026-06-18300CALL0 0107.43FALSE00
2026-06-18350CALL0 0166.37FALSE00
2026-06-182.50PUT0 00FALSE00
2026-06-1850PUT0 0299.27FALSE00
2026-06-187.50PUT0 0213.16FALSE00
2026-06-18100PUT0 090.77FALSE00
2026-06-1812.50PUT0 082.42FALSE00
2026-06-18150PUT0 076.75TRUE00
2026-06-1817.50PUT0 080.82TRUE00
2026-06-18200PUT0 062.64TRUE00
2026-06-1822.50PUT0 073.25TRUE00
2026-06-18257.7PUT0 10TRUE00
2026-06-18300PUT0 00TRUE00
2026-06-18350PUT0 00TRUE00

Latest OPRX Trades:

Date Shares Price
Jun 13, 2022 7:59 PM EST1$25.31
Jun 13, 2022 7:59 PM EST85$25.28
Jun 13, 2022 7:59 PM EST30$25.32
Jun 13, 2022 7:59 PM EST23$25.32
Jun 13, 2022 8:45 PM EST2$25.99

OptimizeRx Corporation (OPRX) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-07-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1448431/000121390020016585/0001213900-20-016585-index.htm
2020-02-27SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1448431/000103347520000005/0001033475-20-000005-index.htm
2020-02-288-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1448431/000121390020004998/0001213900-20-004998-index.htm
2020-03-028-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1448431/000121390020005137/0001213900-20-005137-index.htm
2020-03-038-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1448431/000121390020005258/0001213900-20-005258-index.htm
2020-03-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1448431/000121390020005495/0001213900-20-005495-index.htm
2020-03-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1448431/000121390020005596/0001213900-20-005596-index.htm
2020-03-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1448431/000121390020005688/0001213900-20-005688-index.htm
2020-03-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1448431/000121390020005874/0001213900-20-005874-index.htm
2020-03-118-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1448431/000121390020005969/0001213900-20-005969-index.htm
2020-03-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1448431/000121390020006161/0001213900-20-006161-index.htm
2020-03-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1448431/000121390020006356/0001213900-20-006356-index.htm
2020-03-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1448431/000121390020006358/0001213900-20-006358-index.htm
2020-03-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1448431/000121390020006360/0001213900-20-006360-index.htm
2020-03-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1448431/000121390020006361/0001213900-20-006361-index.htm
2020-03-168-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1448431/000121390020006460/0001213900-20-006460-index.htm
2020-03-16NT 10-KNotification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405https://www.sec.gov/Archives/edgar/data/1448431/000121390020006534/0001213900-20-006534-index.htm
2020-03-188-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1448431/000121390020006751/0001213900-20-006751-index.htm
2020-03-258-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1448431/000121390020007331/0001213900-20-007331-index.htm
2020-03-2610-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1448431/000121390020007491/0001213900-20-007491-index.htm
2020-03-314Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1448431/000121390020008137/0001213900-20-008137-index.htm
2020-03-314Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1448431/000121390020008138/0001213900-20-008138-index.htm
2020-03-314Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1448431/000121390020008139/0001213900-20-008139-index.htm
2020-03-314Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1448431/000121390020008140/0001213900-20-008140-index.htm
2020-04-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1448431/000121390020008316/0001213900-20-008316-index.htm
2020-04-028-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1448431/000121390020008456/0001213900-20-008456-index.htm
2020-04-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1448431/000121390020008624/0001213900-20-008624-index.htm
2020-04-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1448431/000121390020008867/0001213900-20-008867-index.htm
2020-04-10S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1448431/000121390020008955/0001213900-20-008955-index.htm
2020-04-168-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1448431/000121390020009315/0001213900-20-009315-index.htm
2020-04-178-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1448431/000121390020009488/0001213900-20-009488-index.htm
2020-04-228-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1448431/000121390020009800/0001213900-20-009800-index.htm
2020-05-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1448431/000121390020010957/0001213900-20-010957-index.htm
2020-05-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1448431/000121390020011117/0001213900-20-011117-index.htm
2020-05-0610-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1448431/000121390020011158/0001213900-20-011158-index.htm
2020-05-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1448431/000121390020011286/0001213900-20-011286-index.htm
2020-05-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1448431/000121390020011394/0001213900-20-011394-index.htm
2020-05-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1448431/000121390020012040/0001213900-20-012040-index.htm
2020-05-198-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1448431/000121390020012894/0001213900-20-012894-index.htm
2020-06-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1448431/000121390020013773/0001213900-20-013773-index.htm
2020-06-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1448431/000121390020014108/0001213900-20-014108-index.htm
2020-06-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1448431/000121390020014568/0001213900-20-014568-index.htm
2020-06-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1448431/000121390020015899/0001213900-20-015899-index.htm
2020-06-268-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1448431/000121390020015991/0001213900-20-015991-index.htm
2020-06-308-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1448431/000121390020016166/0001213900-20-016166-index.htm
2020-07-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1448431/000121390020016579/0001213900-20-016579-index.htm
2020-07-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1448431/000121390020016581/0001213900-20-016581-index.htm
2020-07-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1448431/000121390020016582/0001213900-20-016582-index.htm
2020-07-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1448431/000121390020016584/0001213900-20-016584-index.htm
2020-07-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1448431/000121390020016585/0001213900-20-016585-index.htm
2020-07-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1448431/000121390020016870/0001213900-20-016870-index.htm
2020-07-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1448431/000121390020017235/0001213900-20-017235-index.htm
2020-07-10144Report of proposed sale of securitieshttps://www.sec.gov/Archives/edgar/data/1448431/000121390020017236/0001213900-20-017236-index.htm
2020-07-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1448431/000121390020017818/0001213900-20-017818-index.htm
2020-07-228-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1448431/000121390020018238/0001213900-20-018238-index.htm
2020-07-238-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1448431/000121390020018352/0001213900-20-018352-index.htm
2020-07-288-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1448431/000121390020018775/0001213900-20-018775-index.htm
2020-08-0510-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1448431/000121390020020375/0001213900-20-020375-index.htm
2020-08-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1448431/000121390020020566/0001213900-20-020566-index.htm
2020-08-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1448431/000121390020020802/0001213900-20-020802-index.htm
2020-08-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1448431/000121390020020933/0001213900-20-020933-index.htm
2020-08-113Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1448431/000121390020021320/0001213900-20-021320-index.htm
2020-08-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1448431/000121390020021359/0001213900-20-021359-index.htm
2020-08-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1448431/000121390020022333/0001213900-20-022333-index.htm
2020-08-208-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1448431/000121390020023057/0001213900-20-023057-index.htm
2020-08-248-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1448431/000121390020023388/0001213900-20-023388-index.htm
2020-09-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1448431/000121390020025434/0001213900-20-025434-index.htm
2020-09-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1448431/000121390020025765/0001213900-20-025765-index.htm
2020-09-158-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1448431/000121390020026656/0001213900-20-026656-index.htm
2020-09-218-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1448431/000121390020027474/0001213900-20-027474-index.htm
2020-10-01DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1448431/000121390020029583/0001213900-20-029583-index.htm
2020-10-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1448431/000121390020031051/0001213900-20-031051-index.htm
2020-10-16144Report of proposed sale of securitieshttps://www.sec.gov/Archives/edgar/data/1448431/000121390020031790/0001213900-20-031790-index.htm
2020-10-268-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1448431/000121390020033259/0001213900-20-033259-index.htm

OptimizeRx Corporation (OPRX) Insider Transactions:

Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of OptimizeRx Corporation (OPRX). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 1791%
Institutional Ownership: 6576%

Transaction Date Insider Name Insider Title Type Shares Number Shares Price Total Transaction Shares Held After Transaction Link
2020-08-06DOUGLAS P BAKERCHIEF FINANCIAL OFFICERSell10,000.0017.01170,100.00100,671.00https://www.sec.gov/Archives/edgar/data/1448431/000121390020020933/0001213900-20-020933-index.htm
2020-08-13DOUGLAS P BAKERCHIEF FINANCIAL OFFICERSell10,000.0018.00180,000.00100,671.00https://www.sec.gov/Archives/edgar/data/1448431/000121390020022333/0001213900-20-022333-index.htm
2020-08-07DOUGLAS P BAKERCHIEF FINANCIAL OFFICERBuy10,000.002.4624,600.00110,671.00https://www.sec.gov/Archives/edgar/data/1448431/000121390020020933/0001213900-20-020933-index.htm
2020-08-14DOUGLAS P BAKERCHIEF FINANCIAL OFFICERBuy10,000.002.4624,600.00110,671.00https://www.sec.gov/Archives/edgar/data/1448431/000121390020022333/0001213900-20-022333-index.htm
2020-08-07GREGORY D WASSONDirectorBuy15,000.0017.49262,350.0015,000.00https://www.sec.gov/Archives/edgar/data/1448431/000121390020021359/0001213900-20-021359-index.htm
2020-03-04WILLIAM J FEBBOCHIEF EXECUTIVE OFFICERBuy30,000.003.2196,300.00163,267.00https://www.sec.gov/Archives/edgar/data/1448431/000121390020005495/0001213900-20-005495-index.htm
2020-03-30Patrick D SpanglerDirectorBuy2,784.0017,467.00https://www.sec.gov/Archives/edgar/data/1448431/000121390020008140/0001213900-20-008140-index.htm
2020-06-30Patrick D SpanglerDirectorBuy1,937.0019,404.00https://www.sec.gov/Archives/edgar/data/1448431/000121390020016584/0001213900-20-016584-index.htm
2020-06-24WILLIAM J FEBBOCHIEF EXECUTIVE OFFICERBuy45,261.003.21145,287.81208,528.00https://www.sec.gov/Archives/edgar/data/1448431/000121390020015899/0001213900-20-015899-index.htm
2020-06-30WILLIAM J FEBBOCHIEF EXECUTIVE OFFICERBuy21,187.00229,719.00https://www.sec.gov/Archives/edgar/data/1448431/000121390020016579/0001213900-20-016579-index.htm
2020-03-30Ellen O'Connor VosDirectorBuy2,784.0027,022.00https://www.sec.gov/Archives/edgar/data/1448431/000121390020008138/0001213900-20-008138-index.htm
2020-03-30James Paul LangDirectorBuy2,784.0027,792.00https://www.sec.gov/Archives/edgar/data/1448431/000121390020008137/0001213900-20-008137-index.htm
2020-03-31Ellen O'Connor VosDirectorBuy1,000.008.758,750.0028,022.00https://www.sec.gov/Archives/edgar/data/1448431/000121390020008316/0001213900-20-008316-index.htm
2020-06-30James Paul LangDirectorBuy1,937.0029,729.00https://www.sec.gov/Archives/edgar/data/1448431/000121390020016582/0001213900-20-016582-index.htm
2020-06-30Ellen O'Connor VosDirectorBuy1,937.0029,959.00https://www.sec.gov/Archives/edgar/data/1448431/000121390020016585/0001213900-20-016585-index.htm
2020-03-30GUS D HALASDirectorBuy2,784.0059,960.00https://www.sec.gov/Archives/edgar/data/1448431/000121390020008139/0001213900-20-008139-index.htm
2020-06-30GUS D HALASDirectorBuy1,937.0061,897.00https://www.sec.gov/Archives/edgar/data/1448431/000121390020016581/0001213900-20-016581-index.htm
2020-09-02DOUGLAS P BAKERCHIEF FINANCIAL OFFICERSell10,000.0020.00200,000.0080,705.00https://www.sec.gov/Archives/edgar/data/1448431/000121390020025434/0001213900-20-025434-index.htm
2020-07-16DOUGLAS P BAKERCHIEF FINANCIAL OFFICERSell6,667.0015.00100,005.0082,671.00https://www.sec.gov/Archives/edgar/data/1448431/000121390020017818/0001213900-20-017818-index.htm
2020-06-03DOUGLAS P BAKERCHIEF FINANCIAL OFFICERBuy17,421.003.1554,876.1589,338.00https://www.sec.gov/Archives/edgar/data/1448431/000121390020014108/0001213900-20-014108-index.htm
2020-07-17DOUGLAS P BAKERCHIEF FINANCIAL OFFICERBuy8,000.002.4619,680.0090,671.00https://www.sec.gov/Archives/edgar/data/1448431/000121390020017818/0001213900-20-017818-index.htm
2020-09-02DOUGLAS P BAKERCHIEF FINANCIAL OFFICERBuy10,000.002.4624,600.0090,705.00https://www.sec.gov/Archives/edgar/data/1448431/000121390020025434/0001213900-20-025434-index.htm